Ozempic, a weight loss drug, is causing a saggy, sunken face known as the “Ozempic face.” This adverse effect is due to a loss of facial volume and is being addressed by the pharmaceutical company Galderma through the use of fillers such as Sculptra and Restylane. The CEO of Galderma is confident in the growth potential of this market and is looking to capitalize on the surge of facial filler requests due to Ozempic use.
Extreme weight loss in a short period of time can lead to a loss of skin elasticity and a drooping complexion. This has been observed in celebrities who have lost weight rapidly due to the GLP-1 agonist jab, including John Goodman, Robbie Williams, and Sharon Osbourne. Sharon Osbourne, in particular, has experienced significant changes in her facial appearance, including sunken eyes, hollow cheeks, loss of volume, and increased wrinkling. This has raised concerns among experts in the field of plastic surgery.
Scott Disick, another celebrity, also experienced dramatic weight loss potentially due to taking Ozempic. After facing public outcry over his emaciated appearance, he reportedly decided to quit the drug. This decision highlights the potential negative impacts of the weight loss drug on physical appearance and overall health. It is important to consider the side effects of medications and make informed decisions about their use.
In addition to the cosmetic effects, Ozempic has also been associated with various other side effects, including bowel obstruction, foul belches, gastrointestinal distress, and stomach paralysis. The drug has faced shortages in supply, leading to an increase in counterfeit medication to meet the demand. These issues raise concerns about the safety and efficacy of Ozempic and highlight the importance of careful monitoring and regulation of weight loss medications.
Galderma is currently studying the effectiveness of fillers for addressing cheek augmentation and contour deficiencies in patients using GLP-1 agonists like Ozempic. These fillers aim to restore facial volume and plumpness that may be lost as a result of rapid weight loss. The use of fillers for cosmetic purposes in individuals experiencing the “Ozempic face” may offer a potential solution to the aesthetic concerns associated with the weight loss drug.
Overall, the use of Ozempic and other weight loss medications can have a range of effects on physical appearance and overall health. It is essential for individuals considering these drugs to be aware of the potential side effects and to consult with healthcare professionals to make informed decisions about their use. The study of fillers by Galderma and other companies may offer promising solutions for addressing the cosmetic concerns associated with the “Ozempic face” and other adverse effects of weight loss drugs.
